Clinical Updates

Drug approvals, guideline changes, and treatment advances

Lassa Fever Vaccine and Therapeutic Trials Mark First Major Clinical Progress in Decades

Two early-phase clinical trials published in Nature Medicine mark the first major advance in Lassa fever countermeasures in over two…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Clinical Updates

AI Detects Invisible Cortical Lesions in MS Patients Using Existing MRI Scans

Artificial intelligence can now detect cortical lesions in multiple sclerosis patients on standard MRI scans…

Exercise Reverses Muscle Aging Via Molecular Switch, New Research Shows

Researchers have identified a molecular switch—the DEAF1 gene—that explains how exercise reverses muscle aging. When…

US Medicaid Work Requirements: Who Loses Coverage and How to Keep It

New Medicaid work requirements are creating barriers to coverage for millions of US beneficiaries. Understanding…

NHS Expands RSV Vaccine Eligibility to Vulnerable Adults This Winter

Starting September 2026, the NHS will extend RSV vaccination to adults aged 65–74 with chronic…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network